H.A.B. Dunning Award
2025 Award Recipient
The Leona M. and Harry B. Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives. Since beginning active grantmaking in 2008, Helmsley has committed more than $4.5 billion for a wide range of charitable purposes. The Helmsley Type 1 Diabetes (T1D) Program is the largest private foundation funder in the world with a focus on T1D, with more than $1 billion to date committed to transform the trajectory of the disease and to accelerate access to 21st century care, everywhere. For more information on Helmsley and its programs, www.visit helmsleytrust.org.
About
The purpose of the award is to recognize an exemplary contribution to APhA and the practice of pharmacy by a pharmaceutical manufacturer, provider of support products or service, or other entities such as wholesalers or chain corporations. The H.A.B. Dunning Award was established in 1982 to honor the former chair of the Board of Hynson, Westcott, and Dunning of Baltimore, MD, who as a longstanding APhA leader was instrumental in the funding and building of the APhA headquarters building in Washington, DC.
Evaluation Criteria
The nominee for the H.A.B. Dunning Award must have made a contribution or contributions to APhA and the practice of pharmacy in a calendar year preceding the presentation of the award. The contribution(s) shall fall in one or more of the following areas:
- Professional and consumer communications
- Pharmacy practice support
- Pharmacy education support
- Sales policy to pharmacists
- Marketing policies and philosophy
- New drug research and development
- Community service involving pharmacists
- Innovative products and service
The selection criteria will be weighted so that contributions to APhA would be 40% and to contributions to the profession would be 60%. The recipient should have had an impact on the profession nationally through their activities with APhA.
Nomination process
The nominator is responsible for submitting a complete award nomination.The nomination is to include the following items:
A letter from the nominator describing the most important achievements of the nominee and explaining why the nominee meets the criteria for the award
Letters of recommendation are optional; two letters are preferred with a maximum of six accepted letters
Selection process
The selection is made by the APhA Board of Trustees based upon careful review of complete nominations.
Nature of award
The award presented at the APhA Annual Meeting consists of a jade crystal etching on a walnut base bearing the likeness of H.A.B. Dunning.
Past recipients
2018 Community Pharmacy Foundation
2014 Cardinal Health and the Cardinal Health Foundation
2012 Novartis Vaccines and Diagnostics, Inc.
2010 VaxServe, a Sanofi Pasteur Co.
2007 Tyco Healthcare/Mallinckrodt
2006 Johnson & Johnson-Merck Consumer Pharmaceuticals Co. and McNeil Consumer Healthcare
2002 Aventis Pharmaceuticals
2001 McNeil Consumer Healthcare
2000 Syncor International Corp.
1999 Wyeth-Ayerst Global Pharmaceuticals
1998 The Knoll Pharmaceutical Co.
1996 Bristol-Myers Squibb Co.
1990 SmithKline Beecham Pharmaceuticals
1988 Marion Laboratories, Inc.
1986 Hoechst Roussel Pharmaceuticals Inc.
1985 McNeil Pharmaceutical
1984 Lederle Laboratories
Return to Main Awards Page